V. Rodríguez-Méndez

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients

S. Castañeda, E. Tomero, J. Troyano, 2020, Journal of clinical medicine.

AB1077 ANTI-IL6-RECEPTOR TOCILIZUMAB IN GRAVES’ ORBITOPATHY. MULTICENTER STUDY OF 46 PATIENTS IN CLINICAL PRACTICE

S. Castañeda, E. Tomero, R. Blanco, 2019, Abstracts Accepted for Publication.

SAT0601 Anti-il6-receptor tocilizumab in graves’ orbitopathy. multicenter study of 29 patients

E. Tomero, M. Gonzalez-gay, R. Blanco, 2018, Saturday, 16 JUNE 2018.